BackCelLBxHealth plc Overview
CelLBxHealth plc

CelLBxHealth plc Return on Equity

Valuation check: CLBX.L's ROE is -475.19%, below the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

-475.19%

Return on Equity

-475.19%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

CelLBxHealth plc (CLBX.L) FAQ

The latest ROE for CLBX.L is -475.19%. That is below the sector sector average of 11.3%. Investors often review this figure alongside CelLBxHealth plc's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, CLBX.L currently prints -475.19% for ROE, while the sector average sits near 11.3%. That is roughly 4306.7% below the sector mean. Large gaps often invite a closer look at CelLBxHealth plc's growth, margins, and balance sheet.

Return on Equity shows how effectively CelLBxHealth plc converts resources into returns. At -475.19%, CLBX.L may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CLBX.L's ROE (-475.19%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.